The Utility of Two Rodent Species in Carcinogenic Risk Assessment of Pharmaceuticals in Europe
- 1 February 1997
- journal article
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 25 (1) , 6-17
- https://doi.org/10.1006/rtph.1996.1077
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Marketed Human Pharmaceuticals Reported to be Tumorigenic in RodentsJournal of the American College of Toxicology, 1995
- Hypomethylation of DNA: An epigenetic mechanism involved in tumor promotionMolecular Carcinogenesis, 1994
- Neoplastic Lesions of Questionable Significance to HumansToxicologic Pathology, 1994
- Rodent Carcinogenicity Bioassay: Past, Present, and FutureToxicologic Pathology, 1994
- IFSTP guidelines for the design and interpretation of the chronic rodent carcinogenicity bioassayExperimental and Toxicologic Pathology, 1992
- Mouse Liver Carcinogenesis: Mechanisms and Relevance*1Fundamental and Applied Toxicology, 1991
- Detection of human carcinogensNature, 1991
- Consideration of both genotoxic and nongenotoxic mechanisms in predicting carcinogenic potentialMutation Research/Reviews in Genetic Toxicology, 1990
- Interspecies extrapolation in carcinogenesis: prediction between rats and mice.Environmental Health Perspectives, 1989
- ras GENESAnnual Review of Biochemistry, 1987